Introduction
Obesity has emerged as one of the most important and prevalent public health problems in the United States. More than one-third of US adults -over 72 million people -are obese, defined as a body mass index (BMI) 30 kg/m 2 [1] . Obesity is associated with several major, modifiable cardiovascular risk factors, including hypertension, dyslipidemia, and diabetes [2] . Hence, obesity and its cardiovascular consequences are common, serious health problems that physicians routinely encounter in their medical practice. Furthermore, obese persons use more health care and have higher health care costs than nonobese individuals [3] .
Numerous trials have demonstrated the efficacy of behavioral interventions as a means to reduce weight and improve short-term health outcomes in overweight or obese adults [4] [5] [6] [7] [8] [9] . However, few of these trials have been conducted in the primary care setting [6] [7] [8] [9] . Furthermore, in most trials, primary care physicians have had a limited role in delivering the interventions or promoting weight loss [10] . Nonetheless, the medical setting provides a potentially effective opportunity to advocate lifestyle changes, including weight loss, as a means to promote health. Indeed, the US Preventive Services Task Force recommends that 'clinicians screen all adult patients for obesity and offer intensive counseling and behavioral interventions to promote sustained weight loss for obese adults' [11] . However, this appears to occur infrequently in daily medical practice.
To evaluate the effectiveness of interventions delivered in routine clinical practice, in December 2005, the National Heart, Lung, and Blood Institute (NHLBI) issued a request for applications (RFA) entitled, 'Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions,' for cooperative agreements (U01) to conduct randomized clinical trials in these settings. Unlike traditional multi-center trials that implement the same protocol across study sites, this RFA proposed that each center implement its own interventions and collaborate with the other RFA-funded trials to use several common measures. Because the optimal approach for weight loss in routine medical settings is uncertain, NHLBI believed it would be beneficial to develop and evaluate multiple interventions, rather than testing one or two interventions in a traditional multi-center trial. In September 2006, three institutions were funded under the RFA: Washington University (St. Louis, MO)/Harvard University (Boston, MA), Johns Hopkins University (Baltimore, MD), and the University of Pennsylvania School of Medicine (Philadelphia, PA). Each study is conducted independently under the direction of a site principal investigator, and final data collection will occur in the spring of 2011. Although the trials share some common design features, each trial has distinct study aims and is implementing distinct interventions. To promote standardization where reasonable, the three trials formed a collaborative organization, the 'Practicebased Opportunities for Weight Reduction (POWER) Trials Collaborative Research Group.' The objectives of this article are to: (1) describe the common and distinct features of the three trials; (2) describe key processes and characteristics of this Collaborative Research Group; and (3) discuss the advantages and disadvantages of this novel organizational approach to organizing multi-center efforts.
Methods
The POWER Trials Collaborative Research Group consists of three individual studies: 'Be Fit, Be Well' (Washington University/Harvard University), 'POWER Hopkins' (Johns Hopkins University), and 'POWER-UP' (University of Pennsylvania). All three trials started a one-year recruitment period in early 2008. Figure 1 shows the timeline of the Collaborative Research Group, and Table 1 presents the key features of the three trials. In total, approximately 1100 participants were recruited from 15 participating clinics. Common components were established to facilitate potential crosssite comparisons, but each protocol also incorporated distinct, trial-specific elements including different interventions and different secondary outcome measurements. The common components included some inclusion and exclusion criteria, a common primary outcome (change in weight from baseline to 24 months), standardized physical measurements, several questionnaires, and a common analysis plan for the primary analysis of principal outcomes. A single Resource Coordinating Unit (RCU) provides administrative support to the Collaborative Research Group. Each study was approved by a local Institutional Review Board. NHLBI established a common Protocol Review Committee (PRC), that was responsible for approving all the trials, and a single Data and Safety Monitoring Board (DSMB), to monitor the trials.
Description of the three trials
The 'Be Fit, Be Well' study is being conducted by investigators from Washington University, Harvard University, and Kaiser Permanente. This study recruited participants from three community health centers in the Boston area: participants are predominantly low-income and are from racial/ ethnic minority groups. Participants were randomized to one of the two arms: The Usual Care group received NHLBI's 'Aim for Healthy Weight' brochure and continued their medical care as usual. Participants in the Intervention group were assigned a health coach who provides support through 18 counseling phone calls and 12 bimonthly group sessions. Participants set behavior change goals, self-monitor their progress, and receive skill training using either a website or a combination of telephone-based interactive voice response system and print materials. Additionally, the participants received tailored 'prescriptions' for weight-related behavioral changes, as well as plans to increase the use of community resources.
The 'POWER Hopkins' at Johns Hopkins University recruited participants from six primary care practices in the Baltimore area. Participants were randomized to one of the three arms. Those assigned to the control condition, selfdirected (SD), received written materials as well as ongoing access to a static web page. Participants assigned to the call-center directed (CCD) intervention are receiving a multi-channel, behavioral intervention with telephone, web, and e-mail contacts, without in-person visits, implemented by trained coaches of Healthways, Inc., a disease management company. Those assigned to the inperson directed intervention (IPD) receive a multichannel behavioral intervention with in-person, group, and individual sessions, along with telephone, web, and e-mail contacts. The IPD interventions are being delivered by coaches at the Hopkins clinical center. Both active interventions use established behavioral techniques to accomplish weight loss (i.e., frequent contact; selfmonitoring of weight and physical activity; use of food records; and accountability), and a web-based hub to facilitate communication among counselors, participants, and the primary care provider (PCP) as well as to promote behavior change in participants. At Hopkins, PCPs have a supportive, rather than a primary role in delivering the interventions. At routinely scheduled visits, the PCP reviews the participants' weight loss reports and encourages participants in the CCD and IPD interventions to remain active in the weight loss program. Common exclusion criteria MI, stroke, or ASCVD procedure within 6 months; serious medical condition likely to hinder accurate measurement of weight, or for which weight loss is contraindicated, or which would cause weight loss; prior or planned bariatric surgery; use of prescription weight loss medication or overthe-counter orlistat within 6 months; chronic use of medications likely to cause weight gain or prevent weight loss; intentional or unintentional weight loss within 6 months of enrollment (5% of body weight)
Recruitment 'POWER-UP' at the University of Pennsylvania (UP) recruited participants from six primary care practices within the Penn Medicine system. Individuals were randomized to one of three interventions: usual care, brief lifestyle counseling, or enhanced brief lifestyle counseling. Participants in the usual care condition receive educational materials (i.e., NHLBI's 'Aim for a Healthy Weight') that are distributed at quarterly visits with a PCP. Those in the brief lifestyle counseling condition receive the same PCP visits, plus 26 brief counseling sessions with an auxiliary health care provider (e.g., a medical assistant). During the first year, participants receive 14 lifestyle counseling visits, scheduled at approximately monthly intervals. Visits that cannot be completed on-site may be conducted by phone. During the second year, the participants are provided 12 lifestyle counseling sessions, at least six of which are scheduled in-person visits, with the option of conducting others by phone (in view of time or travel constraints). Participants in the enhanced brief lifestyle counseling condition receive the same treatment as those in the brief lifestyle counseling group, plus the choice of adjunctive meal products or pharmacotherapy (i.e., orlistat or sibutramine). PCPs and auxiliary health care providers were trained and certified in implementing the protocol. Extensive attention was devoted to educating the PCPs about the use of pharmacotherapy. At the start of the intervention, the physicians reviewed with the participants the potential benefits and risks of both meal replacements and weight loss medications and asked the participants to choose the approach they preferred (i.e., meal replacements vs medications). Participants did not begin their adjunctive treatment until the third visit with their lifestyle coach, to allow time to consider their choices.
Developing common protocols
During the early phase of the studies, the NHLBI project officer and the principal investigators of each trial established a Steering Committee to set policies for the group, establish subcommittees and ad hoc working groups, and resolve cross-study issues. The following sections describe the key cross-trial components.
Eligibility
After extensive deliberations, the Collaborative Research Group decided that some eligibility criteria would be identical for the three studies (e.g., all participants must have a BMI 30 and 50 kg/m 2 and weight 400 lbs), while other criteria would be trial specific (Table 1) . For example, participants in the 'Be Fit, Be Well' study were required to have treated hypertension; participants in 'POWER Hopkins' could have any of the major weightrelated cardiovascular disease (CVD) risk factors (hypertension, dyslipidemia, or diabetes, whether or not the condition was treated with medication); and participants in the 'POWER-UP' trial were required to have at least two components of the metabolic syndrome.
Recruitment. As shown in Table 1 , the three studies implemented different recruitment strategies which largely reflected the study populations, arrangements with clinical practices, and other logistical considerations. The Collaborative Research Group provided a forum to share the best practices and lessons learned about recruitment strategies.
Intervention monitoring. Comprehensive reviews of behavioral weight loss studies were conducted independently by each trial site as part of the grant preparation. The three trials implemented different interventions, but shared information and discussed common issues related to staff training, delivery, and quality assurance and control, particularly related to intervention fidelity. The Collaborative Research Group also developed a common approach to report, compare, and monitor intervention.
Outcomes. The three trials adopted a common primary outcome: change in weight from baseline to month 24. The Collaborative Research Group required the use of specific blood pressure devices and scales and implemented standardized protocols for physical measurements (including weight, height, and blood pressure) from other established studies (e.g., ACCORD [12] and OMNI-Heart Trials [13] ). Measurement training and certification sessions were conducted annually and led by master trainers for staff involved in the study data collection.
Common questionnaires. During the developmental phase, the Collaborative Research Group reviewed relevant literature and had extensive discussions before selecting common questions and survey instruments to capture the following data: demographic characteristics, weight history, medical history, fruit and vegetable intake, fat intake, quality of life, physical activity, depression, sleep quality, and cost to participants. A survey was designed by the Research Group to describe current weight management practices by providers in their respective clinic settings.
Data collection mechanisms. The three trials chose to use different mechanisms to collect self-reported data. 'Be Fit, Be Well' used a computer-assisted data entry system for the participants to enter data onsite. In 'POWER Hopkins', a study website was developed for the participants to complete questionnaires while at home, prior to clinic visits. In 'POWER-UP', standard paper questionnaires were developed for participants to complete on-site. Although the three studies implemented their own quality control procedures, investigators and study staff exchanged local experiences through the Collaborative Research Group structure to further improve local operations.
Analysis approaches. Each trial performed its own sample size calculations for its grant application, but after the grants were awarded, the statisticians in the Collaborative Research Group re-computed the sample size and power using a common, strategic approach. For example, studies used the same minimal detectable weight change difference, the same population standard deviation, and the same structure and values for longitudinal correlation of repeated weights. 'POWER Hopkins' and 'POWER-UP' trials also used a common approach to multiple comparisons for their three group designs. These commonalities produced an identical target sample size of 390 for these two trials. 'Be Fit, Be Well' required a smaller sample size (n ¼ 360), because no multiplicity adjustment was needed for the two-arm trial. In addition, the Collaborative Research Group developed a common approach for accommodating missing data and for outlier detection.
Cost analysis. The Collaborative Research Group developed a data collection template to obtain intervention-related cost data and recommended common questionnaires (e.g., EuroQoL [14] ) to capture medical events, quality of life, and cost to participants. 'Be Fit, Be Well' and 'POWER-UP' adapted a similar approach and are using monthly recall from physicians, interventionists, coordinators, and investigators to estimate the time spent in different activities such as recruitment, intervention, or administration. 'POWER Hopkins', on the other hand, is directly sampling site intervention staff in representative weeks to document the time spent in interventions. For the cost analyses, all sites plan to apply standard labor rates at the national level, in addition to the local rates. The goal is to estimate the total intervention costs, costs associated with interventions relative to the comparison group, costs per participant, and the marginal costs per incremental improvement in the primary outcome.
Safety monitoring. Based on NIH policies and guidelines recommended by the common DSMB, the Collaborative Research Group developed and standardized reporting procedures and formats to document adverse events and unanticipated problems. Annual safety training sessions are conducted to help ensure a standardized approach across the studies.
Dissemination. The Collaborative Research Group plans to disseminate the main results to target audiences through collaborative efforts. Targeted audiences include participants, health care providers, professional organizations, health care organizations, insurance companies, and policy makers. To translate and maximize the relevance of research findings to clinical settings, the Collaborative Research Group is developing plans according to the RE-AIM framework [15] , which evaluates the representativeness of programs and consistency of implementation across different settings, interventionists, and patient populations.
Resource coordinating unit
In the POWER Collaborative Research Group, a single coordinating unit at Johns Hopkins University was funded to support administrative functions and certain scientific activities for the three trials. This RCU assisted in developing standardized protocols for the physical measurements and common questionnaires. It also developed standardized DSMB reports. Another function of the RCU is to design and maintain a Collaborative Research Group website to provide up-to-date information, document repository, and other resources. The RCU continues to arrange and coordinate conference calls and in-person meetings, and provide monthly reports on recruitment and retention to monitor progress at each study. The RCU is also developing a public access website to facilitate the dissemination of study results.
Discussion

Comparison with traditional trials
The POWER Trials Collaborative Research Group is a unique collaborative program of three independent trials with the goal of testing the effectiveness of multiple, distinct weight loss interventions for obese individuals in out-patient settings. Here, we compare the 'hybrid' model of the POWER Collaborative Research Group to other types of trial organizations, namely, a single-center clinical trial, a traditional multi-center trial with a common protocol, and a research network with one or multiple protocols implemented simultaneously or sequentially (Table 2) .
Unlike other trial organizational structures, in the hybrid model, each trial is conducted independently under the direction of the site principal investigator. This model provides an opportunity to evaluate multiple interventions when there is insufficient evidence to mount a single, large-scale multi-center trial that tests one or two interventions. Because there was no well-accepted approach The NIH Research Project (R01) grant is an award made to support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing the investigator's specific interest and competencies, based on the mission of the NIH. b The NIH U01or U54 is a cooperative agreement award mechanism in which the principal investigator retains the primary responsibility and dominant role for planning, directing, and executing the proposed project. NIH staff (consisting of a Scientific Coordinator and Technical Advisory Group) will have a substantial scientific and programmatic involvement during performance of the planned activity. c
The NIH contract is an award instrument establishing a binding legal procurement relationship between NIH and a recipient obligating the latter to furnish a product or service defined in detail by NIH and binding the institute to pay for it.
to weight loss in the medical setting, such an approach was deemed appropriate for this research program. Nonetheless, to maximize what NHLBI can learn from this hybrid model, some degree of administrative and scientific coordination was needed across trials. In traditional multi-center trials or research networks, a Data Coordinating Center provides administrative and scientific coordination related to protocol development and standardization of data collection, as well as data management and analysis. On the other hand, the hybrid model utilizes a smaller scale unit, termed the RCU in POWER, which coordinates administrative and various scientific components, but is not taking primary responsibilities for data collection, management, or analysis. For quality control, individual trials in the POWER Collaborative Research Group set local policies and procedures, while trials share information and learn from each other through regular conference calls, meetings, and informal site visits. A single DSMB monitors quality and safety with side-by-side comparison from each trial. During the dissemination stage, the Collaborative Research Group will disseminate the principal findings collectively, as well as individually.
Trial sponsors have different levels of involvement in studies, depending on the type of funding mechanism. For investigator-initiated trials (e.g., R01), which are often single centers, the NHLBI project officer has a minimal involvement in the trial design and its conduct as these are funded through grant mechanisms. In contrast, NHLBI staff are heavily engaged in the design and implementation of trials funded through contract mechanisms. Many multi-center trials are funded through contracts. The POWER Trials are funded through the cooperative agreement U grant mechanism. In this mechanism, NHLBI has a collaborative role on advising the design and implementation of trials.
In terms of costs, the hybrid model does not fund a large, expensive data coordinating center. However, in the hybrid model and in single-center trials, each trial must instead develop its own data collection, management, and analysis infrastructure. It is not currently known as to whether this may or may not actually exceed the costs of a single data coordinating center.
Lessons learned from the collaborative research group structure
The hybrid model implemented by the POWER Collaborative Research Group has several potential advantages. First, the Collaborative Research Group design can test several interventions simultaneously (five interventions in POWER). Second, the Collaborative Research Group enhances the expertise in areas that might not have been the case in a single trial. For example, the POWER Collaborative Research Group brings together three senior statisticians from different institutions to guide and develop the analysis plan with excellent interactions among biostatisticians. In contrast, most multi-center trials or research networks rely on one or two senior statisticians from the data coordinating center. In addition, specific expertise at one site (e.g., dissemination, cost analysis, and safety) can be shared with other sites. Finally, the efforts to standardize collection and timing of measurements should enhance the potential for pooled analyses and comparisons across trials.
Nevertheless, there are several challenges associated with this mechanism. First, the decisionmaking process can be complex. Since this is a relatively new way to conduct multi-center trials, it was often unclear which aspects of the trials should be identical. For example, early discussion revolved around philosophical considerations, that is, what constitutes an effectiveness trial, particularly with respect to the different study populations. One trial enrolls participants whether or not they are interested in weight loss. Another trial enrolls individuals as long as they expressed interest in losing weight, while the third trial is somewhat more selective and conducted a brief behavioral assessment prior to enrollment. Other issues include medical eligibility criteria, data collection elements, outcome variables, measurement protocols, PCP role, and logistic issues (e.g., paper vs computer-based data entry).
Another challenge relates to maximizing the potential for pooling data. While the trials collected weight in a similar fashion, there were numerous other differences, particularly the interventions and some enrollment criteria. Also, the RCU was not designed to receive data from the individual trials and perform pooled analyses, and its funding to perform pooled analyses is limited. Hence, while such analyses are deemed desirable, pooled data analyses will likely be performed by one of the trial sites, rather than the RCU.
A third challenge relates to trial monitoring. The NHLBI appointed one PRC to approve the independent protocols, and a single DSMB to then monitor them. Monitoring three trials by a single DSMB has required additional efforts to present standardized, concise reports to the DSMB, and to conduct efficient and well-organized DSMB meetings. However, benefits of a common DSMB include in-depth understanding by its members of the common measures, eligibility criteria, and analytic plans and insights gained by evaluating three, related protocols, facilitated communication of lessons learned in monitoring one study to other studies, and conservation of data monitoring resources in clinical trials community.
Conclusion
The POWER Trials Collaborative Research Group is a case study of an alternative organizational model to conduct independent, yet coordinated trials. This article has highlighted the characteristics of the Collaborative Research Group composed of three trials and one RCU, and discussed the currently known advantages and disadvantages of this hybrid model.
With additional NHLBI RFAs implementing this model, this model may have a more prominent role in future federally sponsored clinical trials. Given the substantial interest in comparative effectiveness research, the Collaborative Research Group model offers an opportunity to test different intervention strategies simultaneously. Nevertheless, the ultimate utility of this model will not be fully understood until after completion of the trials.
